Reference is made to the Agreement and Plan of Merger, dated as of the date hereof (the "Merger Agreement"), by and between Merck & Co., Inc., a New ---------------- Jersey corporation ("Parent"), PV Acquisition Corp., a Delaware corporation and...Merck & Co Inc • May 10th, 2000 • Pharmaceutical preparations
EXHIBIT 2 AGREEMENT AND PLAN OF MERGERAgreement and Plan of Merger • May 10th, 2000 • Merck & Co Inc • Pharmaceutical preparations • Delaware
1 EXHIBIT 3 STOCK OPTION AGREEMENT STOCK OPTION AGREEMENT, dated as of July 30, 1999 (the "Agreement"), among Merck & Co., Inc., a New Jersey corporation (the "Grantee"), MC Subsidiary Corp., a Delaware corporation and a wholly owned subsidiary of the...Stock Option Agreement • August 6th, 1999 • Merck & Co Inc • Pharmaceutical preparations • Delaware
EXHIBIT 99.(d)(6) FIRST AMENDMENT TO RIGHTS AGREEMENT AMENDMENT made and entered into as of the 4th day of May, 2000, by and between ProVantage Health Services, Inc. (the "Company") and Norwest Bank Minnesota, National Association (the "Right Agent"),...Rights Agreement • May 10th, 2000 • Merck & Co Inc • Pharmaceutical preparations • Delaware
OFLimited Liability Company Agreement • March 23rd, 2001 • Merck & Co Inc • Pharmaceutical preparations • Delaware
1 EXHIBIT 2 SHAREHOLDERS AGREEMENT SHAREHOLDERS AGREEMENT (this "Agreement") dated as of July 30, 1999 among the persons listed on Schedule 1 hereto (each, a "Holder" and, collectively, the "Holders"), Merck & Co., Inc., a New Jersey corporation...Shareholders Agreement • August 6th, 1999 • Merck & Co Inc • Pharmaceutical preparations • Delaware
EXHIBIT 1 MERCK & CO., INC. MEDIUM-TERM NOTES, SERIES F DISTRIBUTION AGREEMENTDistribution Agreement • January 13th, 2005 • Merck & Co Inc • Pharmaceutical preparations • New York
JOINT FILING AGREEMENTJoint Filing Agreement • May 10th, 2000 • Merck & Co Inc • Pharmaceutical preparations
1Q `01 1Q `00 % CHG. ---------------------------------------------------------- ----------------------Merck & Co Inc • April 20th, 2001 • Pharmaceutical preparations
RECITALNon-Qualified Stock Option Agreement • March 20th, 1996 • Merck & Co Inc • Pharmaceutical preparations • New Jersey
2- 3 contained in the latest registration statement, to the Representatives for each of the other Underwriters, have been declared effective by the Commission in such form; other than a Registration Statement, if any, increasing the size of the...Merck & Co Inc • May 3rd, 1999 • Pharmaceutical preparations • New York
EXHIBIT 3 STOCKHOLDER AGREEMENT STOCKHOLDER AGREEMENT (this "Agreement") dated as of May 4, 2000 among ShopKo Stores, Inc., a Wisconsin corporation, SKO Holdings, Inc. a Delaware corporation and a wholly owned subsidiary of ShopKo Stores, Inc....Stockholder Agreement • May 10th, 2000 • Merck & Co Inc • Pharmaceutical preparations • Delaware
RECITALSEmployment Agreement • May 10th, 2000 • Merck & Co Inc • Pharmaceutical preparations • New Jersey
BY AND AMONGAgreement and Plan of Merger • May 21st, 2001 • Merck & Co Inc • Pharmaceutical preparations • Delaware
Exhibit 1.1 MERCK & CO., INC. DEBT SECURITIES UNDERWRITING AGREEMENTPricing Agreement • February 13th, 2003 • Merck & Co Inc • Pharmaceutical preparations • New York
1 AGREEMENT FOR PURCHASE AND SALE OF SECURITIES THIS AGREEMENT FOR PURCHASE AND SALE OF SECURITIES (the "Agreement") is made and entered into this 25th day of September, 1998, by and between Merck-Medco Managed Care, L.L.C., a Delaware limited...Agreement for Purchase and Sale • September 25th, 1998 • Merck & Co Inc • Pharmaceutical preparations • Delaware
2- 3 the various parts of such registration statements, including all exhibits thereto and the documents incorporated by reference in the prospectus contained in such registration statements at the time such part of such registration statements became...Terms Agreement • October 23rd, 1997 • Merck & Co Inc • Pharmaceutical preparations • New York
AMENDMENTMerck & Co Inc • May 10th, 2000 • Pharmaceutical preparations
EXHIBIT 99.(d)(12) CONFIDENTIALITY AGREEMENT ------------------------- THIS CONFIDENTIALITY AGREEMENT (this "Agreement") is made as of this 8th day of December, 1999 between PROVANTAGE HEALTH SERVICES, INC., a Delaware corporation with its principal...Confidentiality Agreement • May 10th, 2000 • Merck & Co Inc • Pharmaceutical preparations • Wisconsin
2- 3 the Commission under the Act), each in the form heretofore delivered to the Representatives on or prior to the date hereof; and no stop order suspending the effectiveness of the Initial Registration Statement, any post- effective amendment...Merck & Co Inc • September 25th, 1997 • Pharmaceutical preparations • New York
MERCK & CO., INC.Merck & Co Inc • September 25th, 1997 • Pharmaceutical preparations • New York
WHEREAS, Merck-Medco, the Employee and certain other members have entered into a Limited Liability Corporation Agreement, dated as of November 27, 2000 (the "LLC Agreement"), pursuant to which the Employee will become a member ------------- of Merck...Employment Agreement • March 23rd, 2001 • Merck & Co Inc • Pharmaceutical preparations • New Jersey
AGREEMENT AND PLAN OF MERGER by and among MERCK & CO., INC., SPINNAKER ACQUISITION CORP. a wholly owned subsidiary of MERCK & CO., INC. and SIRNA THERAPEUTICS, INC. Dated as of October 30, 2006Agreement and Plan of Merger • November 3rd, 2006 • Merck & Co Inc • Pharmaceutical preparations • Delaware
AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of October 30, 2006, by and among MERCK & CO., INC., a New Jersey corporation (“Parent”), SPINNAKER ACQUISITION CORP., a Delaware corporation and a wholly-owned subsidiary of Parent (“Merger Sub”), and SIRNA THERAPEUTICS, INC., a Delaware corporation (the “Company”).
REGISTERED REGISTERED No. FXR-______________ PRINCIPAL CUSIP No.: _______________ AMOUNT (and Specified Currencies if other than U.S. dollars):Merck & Co Inc • January 13th, 2005 • Pharmaceutical preparations
1 STOCK PURCHASE AGREEMENT This Agreement is made as of this 16th day of June, 1999 by and between Mr. Raymond V. Gilmartin ("Seller") and Merck & Co., Inc., a New Jersey corporation having its principal offices at One Merck Drive, P.O. Box 100,...1 Stock Purchase Agreement • August 12th, 1999 • Merck & Co Inc • Pharmaceutical preparations
BETWEEN ASTRA AB ANDLicense and Option Agreement • August 12th, 1998 • Merck & Co Inc • Pharmaceutical preparations • New York
DESIGNATED LIBOR DESIGNATED CMT PAGE: MATURITY INDEX:Merck & Co Inc • January 13th, 2005 • Pharmaceutical preparations
2- 3 (b) The Option may be exercised by Parent, in whole (but not in part), if after the date hereof the Merger Agreement shall be terminated pursuant to:Voting and Stock Option Agreement • May 21st, 2001 • Merck & Co Inc • Pharmaceutical preparations • Delaware
ii- 4 AGREEMENT AND PLAN OF MERGER (hereinafter called this "Agreement"), dated as of July 30, 1999, among SIBIA Neurosciences, Inc., a Delaware corporation (the "Company"), Merck & Co., Inc., a New Jersey corporation ("Parent"), and MC Subsidiary...Agreement and Plan • August 6th, 1999 • Merck & Co Inc • Pharmaceutical preparations • Delaware
AGREEMENT AND PLAN OF MERGER by and among MERCK & CO., INC., SCHERING-PLOUGH CORPORATION, BLUE, INC., and PURPLE, INC. March 8, 2009Agreement and Plan of Merger • March 10th, 2009 • Merck & Co Inc • Pharmaceutical preparations
THIS AGREEMENT AND PLAN OF MERGER is made as of March 8, 2009, by and among Merck & Co., Inc., a New Jersey corporation (“Mercury”), Schering-Plough Corporation, a New Jersey corporation (“Saturn”), Blue, Inc., a New Jersey corporation and a wholly owned subsidiary of Saturn (“Merger Sub 1”), and Purple, Inc., a New Jersey corporation and a wholly owned subsidiary of Saturn (“Merger Sub 2”). Capitalized terms used and not otherwise defined in this Agreement have the meanings set forth in Article IX.
1 EXHIBIT (c)(4) CONFIDENTIAL DISCLOSURE AGREEMENT This Agreement (the "Agreement") is entered into as of this 23rd day of June 1999 by and between SIBIA Neurosciences, Inc., having a business address of 505 Coast Boulevard South, Suite 300, La Jolla,...Confidential Disclosure Agreement • August 6th, 1999 • Merck & Co Inc • Pharmaceutical preparations • California
Underwriting AgreementUnderwriting Agreement • February 23rd, 2005 • Merck & Co Inc • Pharmaceutical preparations • New York
From time to time Merck & Co., Inc., a New Jersey corporation (the “Company”), proposes to enter into one or more Pricing Agreements (each a “Pricing Agreement”) in the form of Annex I hereto, with such additions and deletions as the parties thereto may determine, and, subject to the terms and conditions stated herein and therein, to issue and sell to the firms named in Schedule I to the applicable Pricing Agreement (such firms constituting the “Underwriters” with respect to such Pricing Agreement and the securities specified therein) certain of its debt securities (the “Securities”) specified in Schedule II to such Pricing Agreement (with respect to such Pricing Agreement, the “Designated Securities”).
WITNESSETH:Incorporate Defined Terms • August 12th, 1998 • Merck & Co Inc • Pharmaceutical preparations
RECITALSTax Matters Agreement • May 10th, 2000 • Merck & Co Inc • Pharmaceutical preparations • Wisconsin
TENDER AND SUPPORT AGREEMENTTender and Support Agreement • December 12th, 2022 • Merck Sharp & Dohme LLC • Pharmaceutical preparations • Delaware
This TENDER AND SUPPORT AGREEMENT (this “Agreement”), dated as of November 19, 2022, is entered into by and among Merck Sharp & Dohme LLC, a New Jersey limited liability company (“Parent”), M-Inspire Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent (“Merger Sub”), and each of the persons set forth on Schedule A hereto (each, a “Stockholder” and together with Parent and Merger Sub, the “Parties” and each, a “Party”). All terms used but not otherwise defined in this Agreement shall have the respective meanings ascribed to such terms in the Merger Agreement (as defined below).
